Literature DB >> 1346159

Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex.

S J Vyas1, J Eichberg, M F Lokhandwala.   

Abstract

Dopamine (DA) is reported to stimulate phospholipase-C (PL-C) in rat renal cortex. Inasmuch as DA activates alpha adrenoceptors and DA receptors, the relative contribution of these receptors to DA-induced activation of PL-C is not yet established. We examined the effect of DA on PL-C activity in rat renal cortical slices prelabeled with myo-2-[3H]inositol in the presence of Li+. PL-C activity was expressed as fractional release (FR) of combined [3H]inositol phosphates expressed as dpm inositol phosphates accumulated/total dpm incorporated X 100. DA (1 mM) produced time-dependent increases in FR up to 60 min. DA (1, 3 and 10 mM) produced 61%, 88% and 110% increases in FR over control. When DA was given in the presence of SCH 23390, a selective DA-1 receptor antagonist, the increase in FR was significantly reduced to 33%, 51% and 62%, respectively, but the increase in FR remained unaffected in the presence of a DA-2 receptor antagonist, domperidone (30 microM). Phentolamine (10 microM) also inhibited the response to DA to 41%, 47% and 43% at the respective concentrations. DA-induced stimulation of PL-C was completely abolished in the combined presence of both SCH 23390 (30 microM) and phentolamine (10 microM). SCH 23390, domperidone or phentolamine alone did not significantly change the basal PL-C activity in renal cortical slices. These results demonstrate that 1) DA stimulates PL-C in rat renal cortex via activation of both DA-1 receptors and alpha adrenoceptors and DA-2 receptors are not involved in this response; and 2) during normal sodium intake, intrarenal DA does not modulate the PL-C activity in rat renal cortex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346159

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.

Authors:  Sang-Min Lee; Andrew Kant; Daniel Blake; Vishakantha Murthy; Kevin Boyd; Steven J Wyrick; Richard B Mailman
Journal:  Neuropharmacology       Date:  2014-06-12       Impact factor: 5.250

3.  Ontogenic aspects of D1 receptor coupling to G proteins and regulation of rat jejunal Na+, K+ ATPase activity and electrolyte transport.

Authors:  M A Vieira-Coelho; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 4.  Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation.

Authors:  Pedro A Jose; Patricio Soares-da-Silva; Gilbert M Eisner; Robin A Felder
Journal:  Biochim Biophys Acta       Date:  2010-02-12

5.  Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.

Authors:  C Chen; M F Lokhandwala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

Review 6.  Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?

Authors:  Sang-Min Lee; Yang Yang; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2014-07-22       Impact factor: 4.030

7.  Differential regulation of renal phospholipase C isoforms by catecholamines.

Authors:  P Y Yu; L D Asico; G M Eisner; P A Jose
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Human kidney-2 cells harbor functional dopamine D1 receptors that require Giα for Gq/11α signaling.

Authors:  Indira D Pokkunuri; Gaurav Chugh; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.